You are currently viewing a new version of our website. To view the old version click .

Antibodies, Volume 9, Issue 3

September 2020 - 23 articles

Cover Story: Monoclonal antibody-based immunotherapy is an important component of numerous cancer treatment regimens. Monoclonal antibodies have many distinct clinical applications due to their multidimensional properties as a therapeutic platform. In order to address therapeutic resistance, an understanding of the complex mechanisms of action underlying monoclonal antibody therapy is needed. Additionally, advancements in therapeutic modalities such as immune checkpoint inhibition as well as combination therapies have proven highly effective and have opened up new areas of research. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (23)

  • Article
  • Open Access
46 Citations
16,297 Views
21 Pages

Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody

  • Jackie Cheng,
  • Meina Liang,
  • Miguel F. Carvalho,
  • Natalie Tigue,
  • Raffaella Faggioni,
  • Lorin K. Roskos and
  • Inna Vainshtein

18 September 2020

Amplification and overexpression of HER2 (human epidermal growth factor receptor 2), an ErbB2 receptor tyrosine kinase, have been implicated in human cancer and metastasis. A bispecific tetravalent anti-HER2 antibody (anti-HER2-Bs), targeting two non...

  • Article
  • Open Access
1 Citations
10,780 Views
13 Pages

Monoclonal Antibodies Generated against Glycoconjugates Recognize Chemical Linkers

  • Jessica Ramadhin,
  • Vanessa Silva-Moraes,
  • Thomas Norberg and
  • Donald Harn

15 September 2020

Monoclonal antibodies (mAbs) that recognize glycans are useful tools to assess carbohydrates’ structure and function. We sought to produce IgG mAbs to the human milk oligosaccharide (HMO), lacto-N-fucopentaose III (LNFPIII). LNFPIII contains th...

  • Article
  • Open Access
4 Citations
6,198 Views
15 Pages

8 September 2020

Antibody–drug conjugates (ADCs) are heterogeneous biotherapeutics and differ vastly in their physicochemical properties depending on their design. The number of small drug molecules covalently attached to each antibody molecule is commonly refe...

  • Review
  • Open Access
35 Citations
8,599 Views
22 Pages

8 September 2020

Atopic dermatitis (AD) is a common skin disease affecting 20% of the population beginning usually before one year of age. It is associated with the emergence of allergen-specific IgE, but also with autoreactive IgE, whose function remain elusive. Thi...

  • Feature Paper
  • Review
  • Open Access
4 Citations
5,551 Views
25 Pages

4 September 2020

We examined the kinetics and mechanisms by which monoclonal antibodies (mAbs) utilize complement to rapidly kill targeted cancer cells. Based on results from flow cytometry, confocal microscopy and high-resolution digital imaging experiments, the gen...

  • Feature Paper
  • Review
  • Open Access
26 Citations
8,435 Views
13 Pages

CD47 as a Potential Target to Therapy for Infectious Diseases

  • Lamin B. Cham,
  • Tom Adomati,
  • Fanghui Li,
  • Murtaza Ali and
  • Karl S. Lang

1 September 2020

The integrin associated protein (CD47) is a widely and moderately expressed glycoprotein in all healthy cells. Cancer cells are known to induce increased CD47 expression. Similar to cancer cells, all immune cells can upregulate their CD47 surface exp...

  • Case Report
  • Open Access
7 Citations
5,321 Views
5 Pages

Severe Intraoperative Anaphylaxis Related to Thymoglobulin during Living Donor Kidney Transplantation

  • Muhammad I. Saeed,
  • Ryan D. Nicklas,
  • Vikas Kumar,
  • Rajan Kapoor and
  • Imran Y. Gani

18 August 2020

Anaphylaxis secondary to thymoglobulin (anti-thymocyte globulin) is a rare condition that can be life threatening. Thymoglobulin is a rabbit-derived T-cell depleting polyclonal immunoglobulin. It is commonly used for induction immunosuppression and/o...

  • Case Report
  • Open Access
10 Citations
6,454 Views
7 Pages

15 August 2020

The Inflammatory Bowel Disease (IBD) population, which may require treatment with immunosuppressive medications, may be uniquely vulnerable to COVID-19 infection. In fact, there is some evidence these medications may inhibit the cytokine storm that i...

  • Case Report
  • Open Access
4 Citations
7,714 Views
6 Pages

Solutions to Avoid False Positives for Rituximab in Pre-Transplant Crossmatches

  • Argentina Colmenero Velazquez,
  • Ignacio Iturrieta-Zuazo,
  • Juan Luis Valdivieso Shephard,
  • Marisa Di Natale,
  • Claudia Rita,
  • Rubén Ballester González,
  • José Luis Castañer Alabau and
  • Israel Nieto Gañán

5 August 2020

Rituximab (anti-CD20) is commonly used as immunotherapy against B cells, in the context of pre-transplant crossmatches, where the presence of rituximab in the tested sera with donor cells can alter their results both by flow cytometry (FCXM) as compl...

  • Communication
  • Open Access
11 Citations
5,439 Views
11 Pages

5 August 2020

Allometric scaling can be used for the extrapolation of pharmacokinetic parameters from adults to children. The objective of this study was to predict clearance of therapeutic proteins (monoclonal and polyclonal antibodies and non-antibody proteins)...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibodies - ISSN 2073-4468